[C-peptide: a by-product of insulin biosynthesis or an active peptide hormone?].
Mavrakanas
Thomas
T
Laboratoire de pharmacologie A, Faculté de médecine, Université Aristote de Thessalonique, 54248 Thessalonique, Grèce. thomas_mavrakanas@yahoo.fr
Bastide
Dominique
D
D000419:Albuminuria / Q000652:urine; D000818:Animals; D015415:Biomarkers / Q000032:analysis; D002096:C-Peptide / Q000032:analysis / Q000502:physiology* / Q000627:therapeutic use; D002147:Calmodulin / Q000502:physiology; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D005919:Glomerular Filtration Rate / Q000502:physiology; D006801:Humans; D007328:Insulin / Q000096:biosynthesis*; D050417:Insulin-Secreting Cells / Q000502:physiology; D024821:Metabolic Syndrome / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000502:physiology; D000254:Sodium-Potassium-Exchanging ATPase / Q000502:physiology
D015415:Biomarkers; D002096:C-Peptide; D002147:Calmodulin; D007328:Insulin; D043562:Receptors, G-Protein-Coupled; D000254:Sodium-Potassium-Exchanging ATPase